Lpath Incorporated

Scott Pancoast - President & CEO

Background: From 1994 to 2004, Mr. Pancoast was managing partner of Western States Investment Corporation, a private San Diego venture capital fund with $30 million to $100 million under management depending on the time period. During that time, he was CEO or interim CEO for six start-up companies and served on the board of directors for over 15 companies, including three public companies. Prior to joining WSIC, he started and ran the Midwest division of a $300 million (in revenues) publicly traded company. He served as the Chairman/President of the San Diego Venture Group during the late 1990s. Mr. Pancoast earned a bachelors degree from the University of Virginia, and an MBA from the Harvard Business School.

Roger Sabbadini, PhD - Founder, Vice President, Chief Scientific Officer

Background: Dr. Sabbadini was a Professor of Biology for 32 years at San Diego State University and is currently a Professor Emeritus of Biology. He founded three biotechnology companies, including Lpath, that were incubated out of SDSU. Dr. Sabbadini has been interested in the role of bioactive lipids in  various diseases, including cancer, ocular disorders, neurotrauma, neuropathic pain, inflammation and heart disease. Dr. Sabbadini’s research focused on developing novel antibody-based therapeutics against bioactive lipids such as the sphingolipid, S1P  and these anti-S1P antibodies are now in Phase 2 clinical trials for ocular disorders and cancer. Dr. Sabbadini earned his Ph.D. at the University of California, Davis.

Gary Atkinson - Vice President & Chief Financial Officer

Background: Mr. Atkinson has more than 20 years of financial management experience. Prior to joining Lpath, he served as the Chief Financial Officer for three private life science companies. In addition, Mr. Atkinson was the Vice President of Finance at Isis Pharmaceuticals, a publicly held pharmaceutical research and development company. He began his career with Ernst & Young, where he earned his CPA designation. Mr. Atkinson is a graduate of Brigham Young University.

Glenn Stoller, M.D. - Head of Lpath Ocular

Background: Dr. Stoller is a practicing retinal-eye surgeon. He received his medical degree from NYU School of Medicine and performed his residency at the Harkness Eye Institute of Columbia Presbyterian Hospital. He completed his fellowship in medical and surgical diseases of the retina at New York Presbyterian Hospital—Cornell Campus in New York City. He has served as an advisor for a number of pharmaceutical companies. He is a former editorial board member of the American Academy of Ophthalmology and an active member of The Retina Society.